LOX rises as a potential survival biomarker: A commentary on “Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme” by Liu et al.

Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients

(2023) Qiong Zhong et al.   Genes & Genomics

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme

(2023) Erheng Liu et al.   Translational Oncology

Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression

(2022) Tanya Liburkin-Dan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma

(2022) Qin-Xuan Xia et al.   Frontiers in Pharmacology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions

(2020) Patrick Y Wen et al.   NEURO-ONCOLOGY